Cargando…
Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review)
Chimeric antigen receptor (CAR) T cell therapy has emerged as a new and breakthrough cancer immunotherapy. Although CAR-T cell therapy has made significant progress clinically in patients with refractory or drug-resistant hematological malignancies, there are numerous challenges in its application t...
Autores principales: | Zhong, Liqiang, Li, Yi, Muluh, Tobias Achu, Wang, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236127/ https://www.ncbi.nlm.nih.gov/pubmed/37274466 http://dx.doi.org/10.3892/ol.2023.13867 |
Ejemplares similares
-
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023) -
CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021) -
Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities
por: Xia, An-Liang, et al.
Publicado: (2017) -
Effect of low-dose total-body radiotherapy on immune microenvironment
por: Chen, Zhuo, et al.
Publicado: (2021) -
Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer
por: Jin, Jing, et al.
Publicado: (2021)